/Companies

Aunitx

1 known investors

Find your way into Aunitx

Sign up to see every warm intro you have to Aunitx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aunitx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Auni Therapeutics develops immunotherapy treatments for food allergies, leveraging intralymphatic immunotherapy (ILIT) protocols and proprietary clinical innovations. The company serves patients with allergic disease and aims to bring next-generation allergen immunotherapies to market.

Founders & leadership

BL
Brad LangCo-Founder & Chief Executive Officer
AP
Amber PattersonCo-Founder & Chief Medical Officer
BPBen Patterson
Ben PattersonCo-Founder & Chief Operating Officer

Investors · 1

Frequently asked questions

What does Aunitx do?
Auni Therapeutics develops immunotherapy treatments for food allergies, leveraging intralymphatic immunotherapy (ILIT) protocols and proprietary clinical innovations. The company serves patients with allergic disease and aims to bring next-generation allergen immunotherapies to market.
Who founded Aunitx?
Aunitx was founded by Brad Lang, Amber Patterson, Ben Patterson.
Who are Aunitx's investors?
Aunitx's investors include JumpStart Equity.